Sign inJoin waitlistJoin the waitlist

Curt Civin

Director · Univ of Maryland Sch of Med

Credentials: · ·

History

Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med
Present

National Cancer Institute
1975–1976
Pediatrics
Boston Children's Hospital
1971–1974
Harvard Medical School
1966–1970

Research

Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells
The Journal of Immunology · 1984 · First of 6 authors · 1,122 citations
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
The Journal of Immunology · 1986 · 1,101 citations
CD34: structure, biology, and clinical utility
Review · Blood · 1996 · 771 citations

DS
Donald Small
12 papers
Michael Kastan
12 papers
AF
Alan Friedman
11 papers
PS
Phillip Steuber
10 papers
Wing-Hang Leung
8 papers
YR
Yaddanapudi Ravindranath
8 papers
SG
Steven Gore
7 papers · 2 as a fellow
Cindy Schwartz
6 papers · 3 as a fellow
EN
Enrico Novelli
6 papers · 2 as a resident
Xiaobing Yu
6 papers · 2 as a resident
BC
Bruce Camitta
5 papers
Bryan Mott
5 papers · 3 as a resident

Grants

Protein Degradation Strategies to Overcome Menin Drug Resistance in Acute Leukemias
National Cancer Institute · R21
PI · $399.8K · University of Maryland Baltimore
2026–2028
Training Grant in Cancer Biology
National Cancer Institute · T32
PI · $5M · University of Maryland Baltimore
2011–2027
Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia
National Cancer Institute · R21
PI · $393.6K · University of Maryland Baltimore
2021–2024
Microfluidic CAR-T Cell Processing Device
National Cancer Institute · R42
PI · $2.1M · Gpb Scientific, Inc.
2018–2022